[Cl:1][C:2]1[N:7]=[CH:6][C:5]([C:8]([OH:10])=O)=[CH:4][C:3]=1[I:11].[Cl:12][C:13]([F:23])([F:22])[O:14][C:15]1[CH:21]=[CH:20][C:18]([NH2:19])=[CH:17][CH:16]=1>>[Cl:1][C:2]1[C:3]([I:11])=[CH:4][C:5]([C:8]([NH:19][C:18]2[CH:20]=[CH:21][C:15]([O:14][C:13]([Cl:12])([F:22])[F:23])=[CH:16][CH:17]=2)=[O:10])=[CH:6][N:7]=1The title compound was prepared in an analogous fashion to that described in Stage 65.1 using 6-Chloro-5-iodo-3-pyridinecarboxylic acid and 4-(chlorodifluoromethoxy)aniline to afford a beige solid. UPLC-MS (Condition 2) tR=1.25 min, m/z=459.0/460.7/462.1 [M+H]+.